glp 1 dual agonist Tirzepatide, a GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology GLP-1R and Diabetes

Such conceptual expansionfrom single-hormone correction to multi-hormonal restorationunderscores the novelty and translational importance of this review

Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation

95% CI 0.270.92)

Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational studies

[DOI] [PubMed] [Google Scholar] 115.DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD

Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same